Vivo Capital, LLC
CIK 1674712 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $1.1B
- Posisi
- 47
- Per tanggal
- 30 Juni 2026
#2.308 dari 9.443 berdasarkan nilai 13F · top 24.4%
Nilai portofolio QoQ: -9.0% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 52,40%
- Bobot 25 kepemilikan teratas
- 87,77%
- Posisi di atas 1%
- 28
- Jumlah posisi efektif
- 24,4
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 13,55% Perkiraan pembelian $155.716.945 · penjualan $353.838.199
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 60,3% masih dipegang
- Posisi baru
- 7
- Meningkat
- 6
- Menurun
- 8
- Tertutup
- 6
Di halaman ini
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Rincian sektor
Healthcare
98,4%
Lainnya/Tidak terpetakan
1,6%
Portofolio lengkap 47 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics, Inc. - Common Stock | $95.015.558 | 8,68% | 5.094.668 | $34.236.169 | |||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $90.766.926 | 8,29% | 271.116 | $-18.421.654 | Turun ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $75.614.188 | 6,90% | 4.127.412 | $-120.996.758 | Turun ×1 | ||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $58.436.050 | 5,34% | 1.682.097 | $37.997.968 | Naik ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $55.289.441 | 5,05% | 414.899 | $28.616.773 | Naik ×1 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $43.131.579 | 3,94% | 1.379.769 | $-1.946.419 | Turun ×1 | ||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $41.918.891 | 3,83% | 2.805.816 | $869.803 | |||
| DRUG Bright Minds Biosciences Inc. - common stock | $39.113.474 | 3,57% | 557.172 | $-1.543.367 | |||
| SVA Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) | $38.192.410 | 3,49% | 5.903.000 | $0 | |||
| TENX Tenax Therapeutics, Inc. - Common Stock | $36.375.000 | 3,32% | 2.500.000 | $33.043.755 | Naik ×1 | ||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $35.414.630 | 3,23% | 6.694.637 | $10.414.632 | Naik ×1 | ||
| DYN Dyne Therapeutics, Inc. - Common Stock | $34.591.320 | 3,16% | 1.557.466 | $6.354.461 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $34.507.725 | 3,15% | 353.998 | $4.800.213 | |||
| ANRO Alto Neuroscience, Inc. Common Stock | $31.901.763 | 2,91% | 1.208.858 | $8.622.577 | Naik ×1 | ||
| DBVT DBV Technologies S.A. - American Depositary Shares | $30.254.031 | 2,76% | 1.844.758 | $-25.471.485 | Turun ×1 | ||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $28.469.645 | 2,60% | 7.299.909 | $-15.268.955 | Turun ×1 | ||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $27.258.000 | 2,49% | 1.400.000 | $8.618.000 | Naik ×1 | ||
| LBRX LB Pharmaceuticals Inc - Common Stock | $25.964.000 | 2,37% | 800.000 | $6.236.000 | |||
| NERV Minerva Neurosciences, Inc - Common Stock | $23.991.246 | 2,19% | 4.322.747 | $-2.053.305 | |||
| DSGN Design Therapeutics, Inc. - Common Stock | $23.338.706 | 2,13% | 1.612.903 | $6.177.418 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $20.022.352 | 1,83% | 1.848.786 | $-3.401.767 | |||
| CAMP CAMP4 Therapeutics Corporation - Common Stock | $18.557.502 | 1,69% | 4.246.568 | $-169.863 | |||
| SNSE Sensei Biotherapeutics, Inc. - Common Stock | $18.050.500 | 1,65% | 722.020 | $-4.707.570 | |||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $17.964.239 | 1,64% | 2.751.032 | Naik ×1 | |||
| CMPX Compass Therapeutics, Inc. - Common Stock | $16.987.961 | 1,55% | 7.757.060 | $-33.507.554 | Turun ×1 | ||
| ANTX AN2 Therapeutics, Inc. - Common Stock | $15.263.618 | 1,39% | 3.153.640 | $4.478.169 | |||
| EDIT Editas Medicine, Inc. - Common Stock | $11.519.010 | 1,05% | 3.555.250 | Naik ×1 | |||
| GERN Geron Corporation - Common Stock | $11.099.900 | 1,01% | 8.671.797 | $-1.821.078 | |||
| Penerbit tidak dikenal (CUSIP: 67613T104) | $10.758.250 | 0,98% | 575.000 | Naik ×1 | |||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $8.923.500 | 0,81% | 1.350.000 | $-850.500 | |||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $8.790.358 | 0,80% | 1.927.710 | $809.639 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $8.404.756 | 0,77% | 671.843 | $-1.612.423 | |||
| MNPR Monopar Therapeutics Inc. - Common Stock | $8.379.395 | 0,77% | 90.500 | $3.420.900 | |||
| AURA Aura Biosciences, Inc. - Common Stock | $8.283.336 | 0,76% | 1.166.667 | Naik ×1 | |||
| SRZN Surrozen, Inc. - Common Stock | $6.747.000 | 0,62% | 260.000 | $-826.800 | |||
| ALXO ALX Oncology Holdings Inc. - Common Stock | $6.592.356 | 0,60% | 3.184.713 | $207.006 | |||
| MSLE Satellos Bioscience Inc. - Common Stock | $6.326.253 | 0,58% | 813.666 | $1.745.313 | |||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $5.082.000 | 0,46% | 275.000 | Naik ×1 | |||
| PEPG PepGen Inc. - Common Stock | $4.185.000 | 0,38% | 2.325.000 | $69.750 | |||
| VALN Valneva SE - American Depositary Shares | $3.991.531 | 0,36% | 763.199 | Naik ×1 | |||
| SERA Sera Prognostics, Inc. - Class A Common Stock | $3.003.801 | 0,27% | 1.650.440 | $-346.592 | |||
| UNCY Unicycive Therapeutics, Inc. - Common Stock | $2.579.500 | 0,24% | 550.000 | $-9.198.147 | Turun ×1 | ||
| TIL Instil Bio, Inc. - Common Stock | $2.251.194 | 0,21% | 292.743 | $-161.008 | |||
| INM InMed Pharmaceuticals Inc. - Common Shares | $1.237.484 | 0,11% | 798.377 | Naik ×1 | |||
| BOLT Bolt Biotherapeutics, Inc. - Common Stock | $278.794 | 0,03% | 72.414 | $-13.759 | |||
| KTTA Pasithea Therapeutics Corp. - Common Stock | $239.904 | 0,02% | 465.471 | $-1.317.876 | Turun ×1 | ||
| DTIL Precision BioSciences, Inc. - Common Stock | $36.746 | 0,00% | 4.675 | $11.033 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| ERAS | Dipangkas | -8.0M | -$121.0M |
| AVBP | Beli lebih banyak | +796K | +$38.0M |
| TRVI | Hanya pergerakan harga | +0 | +$34.2M |
| CMPX | Dipangkas | -1.8M | -$33.5M |
| ABVX | Beli lebih banyak | +175K | +$28.6M |
| DBVT | Dipangkas | -823K | -$25.5M |
| PRAX | Dipangkas | -68K | -$18.4M |
| SABS | Dipangkas | -4.1M | -$15.3M |
| ACRS | Beli lebih banyak | +28K | +$10.4M |
| UNCY | Dipangkas | -1.2M | -$9.2M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| CDTX | 31 Maret 2026 | 956.670 | $211.318.836 | Tidak lagi dilacak |
| VRNA | 31 Des. 2025 | 1.393.432 | $148.693.129 | Tidak lagi dilacak |
| TERN | 30 Juni 2026 | 1.334.418 | $70.350.517 | Tidak lagi dilacak |
| AVDL | 31 Maret 2026 | 2.684.109 | $57.842.549 | Tidak lagi dilacak |
| ZBIO | 31 Maret 2026 | 853.495 | $30.990.403 | 52,9% |
| TRML | 31 Des. 2025 | 591.882 | $28.309.716 | Tidak lagi dilacak |
| AKRO | 31 Des. 2025 | 434.689 | $20.639.034 | Tidak lagi dilacak |
| RZLT | 31 Des. 2025 | 2.112.432 | $19.856.861 | 97,5% |
| MANE | 30 Juni 2026 | 300.000 | $18.945.000 | -12,2% |
| COGT | 30 Juni 2026 | 422.300 | $16.254.327 | -6,3% |
| CTMX | 31 Maret 2026 | 2.884.615 | $12.288.460 | -25,5% |
| ATXS | 31 Des. 2025 | 1.552.685 | $11.303.547 | Tidak lagi dilacak |
| SLNO | 30 Juni 2026 | 294.909 | $9.873.553 | Tidak lagi dilacak |
| ABEO | 31 Maret 2026 | 1.842.751 | $9.711.298 | 36,0% |
| CMPS | 30 Sep. 2025 | 3.362.385 | $9.414.678 | 144,2% |
| IOBT | 30 Sep. 2025 | 6.173.439 | $8.581.080 | Tidak lagi dilacak |
| VSTM | 31 Maret 2026 | 1.106.524 | $8.542.365 | 34,2% |
| CELC | 30 Sep. 2025 | 610.500 | $8.150.175 | 86,2% |
| SLN | 31 Maret 2026 | 1.105.454 | $6.721.160 | 150,7% |
| DCTH | 31 Des. 2025 | 569.526 | $6.122.405 | 68,2% |
| ETNB | 31 Des. 2025 | 376.804 | $5.539.019 | Tidak lagi dilacak |
| PALI | 31 Maret 2026 | 2.293.578 | $5.389.908 | 19,4% |
| RGLS | 30 Juni 2025 | 2.696.426 | $4.718.746 | Tidak lagi dilacak |
| VRDN | 30 Juni 2026 | 166.288 | $3.252.593 | 31,5% |
| CRBP | 31 Maret 2025 | 166.794 | $1.968.169 | 85,5% |
| CMPS | 30 Juni 2026 | 200.000 | $1.106.000 | -1,1% |
| ENGNW | 31 Maret 2026 | 285.046 | $843.736 | -88,8% |
| ALLK | 30 Juni 2025 | 765.500 | $174.228 | Tidak lagi dilacak |
| DBVT | 31 Maret 2025 | 32.020 | $98.942 | 111,0% |
| ALGS | 30 Juni 2025 | 10.199 | $84.142 | -2,8% |
| QTTB | 31 Maret 2025 | 20.559 | $70.723 | 855,8% |